Cargando…
The target therapy of ovarian clear cell carcinoma
Clear cell adenocarcinoma (CCC) of the ovary accounts for 10% of epithelial ovarian cancer and is a distinct entity from other epithelial ovarian carcinomas. It arises from the endometriosis. CCC has specific biological and clinical behavior. Compared with other histological types, CCC shows a chemo...
Autores principales: | Jin, Ying, Li, Yan, Pan, Lingya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181630/ https://www.ncbi.nlm.nih.gov/pubmed/25285014 http://dx.doi.org/10.2147/OTT.S49993 |
Ejemplares similares
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021) -
Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
por: Yamashita, Yoriko
Publicado: (2015) -
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013) -
Hepatic metastases in ovarian cancer
por: Shan, Ying, et al.
Publicado: (2022) -
Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma
por: Zhu, Chenchen, et al.
Publicado: (2021)